Influence of retirement on adherence to statins in the insurance medicine all-Sweden total population data base

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Halava, Heli ^a   Westerlund, Hugo ^b,c   Korhonen, Maarit Jaana ^a   Pentti, Jaana ^d   Kivimäki, Mika ^e   Kjeldgård, Linnea ^c   Alexanderson, Kristina ^c   Vahtera, Jussi ^a,c,d,f  

^a UNIVERSITY OF TURKU   (Finland)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; SIMVASTATIN;

ADULT; AGE; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DATA BASE; DRUG WITHDRAWAL; EDUCATION; FEMALE; HUMAN; INCOME; INSURANCE; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MEDICATION COMPLIANCE; PATIENT COMPLIANCE; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PRIMARY PREVENTION; PROSPECTIVE STUDY; PURCHASING; RETIREMENT; SECONDARY PREVENTION; SEX DIFFERENCE; SWEDEN; SWEDISH CITIZEN; TREATMENT REFUSAL; DYSLIPIDEMIAS; EDUCATIONAL STATUS; EPIDEMIOLOGY; FACTUAL DATABASE; FOLLOW UP; MIDDLE AGED; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

ADULT; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; DYSLIPIDEMIAS; EDUCATIONAL STATUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCOME; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RETIREMENT; SECONDARY PREVENTION; SIMVASTATIN; SWEDEN;

EID: 84939235395     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0130901     Document Type: Article

References (41)

1. Nichols M, Townsend N, Scarborough P, Rayner M. Cardiovascular disease in Europe: Epidemiological update. Eur Heart J. 2013; 34: 3028-3034. doi: 10.1093/eurheartj/eht356 PMID: 24014390
2. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the global burden of disease study 2010. Lancet. 2012; 380: 2224-2260. doi: 10.1016/S0140-6736(12)61766-8 PMID: 23245609
3. European Association for Cardiovascular Prevention & Rehabilitation, Reiner Z, Catapano AL, De Backer G, Graham I, Taskinen MR, et al. ESC/EAS guidelines for the management of dyslipidaemias: The task force for the management of dyslipidaemias of the european society of cardiology (ESC) and the european atherosclerosis society (EAS). Eur Heart J. 2011; 32: 1769-1818. doi: 10.1093/eurheartj/ehr158 PMID: 21712404
4. Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, et al. Adherence to cardiovascular therapy: A meta-analysis of prevalence and clinical consequences. Eur Heart J. 2013; 34: 2940-2948. doi: 10.1093/eurheartj/eht295 PMID: 23907142
5. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353: 487-497. PMID: 16079372
6. Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: A systematic review and meta-analysis. Ann Pharmacother. 2010; 44: 1410-1421. doi: 10.1345/aph.1P150 PMID: 20702755
7. Chan DC, Shrank WH, Cutler D, Jan S, Fischer MA, Liu J, et al. Patient, physician, and payment predictors of statin adherence. Med Care. 2010; 48: 196-202. doi: 10.1097/MLR.0b013e3181c132ad PMID: 19890219
8. Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA. Effect of the medicare part D coverage gap on medication use among patients with hypertension and hyperlipidemia. Ann Intern Med. 2012; 156: 776-784. doi: 10.7326/0003-4819-156-11-201206050-00004 PMID: 22665815
9. Lemstra M, Blackburn D, Crawley A, Fung R. Proportion and risk indicators of nonadherence to statin therapy: A meta-analysis. Can J Cardiol. 2012; 28: 574-580. doi: 10.1016/j.cjca.2012.05.007 PMID: 22884278
10. Krousel-Wood M, Joyce C, Holt E, Muntner P, Webber LS, Morisky DE, et al. Predictors of decline in medication adherence: Results from the cohort study of medication adherence among older adults. Hypertension. 2011; 58: 804-810. doi: 10.1161/HYPERTENSIONAHA.111.176859 PMID: 21968751
11. Kivimaki M, Batty GD, Hamer M, Nabi H, Korhonen M, Huupponen R, et al. Influence of retirement on nonadherence to medication for hypertension and diabetes. CMAJ. 2013; 185: E784-790. doi: 10. 1503/cmaj.122010 PMID: 24082018
12. Westerlund H, Kivimaki M, Singh-Manoux A, Melchior M, Ferrie JE, Pentti J, et al. Self-rated health before and after retirement in france (GAZEL): A cohort study. Lancet. 2009; 374: 1889-1896. doi: 10. 1016/S0140-6736(09)61570-1 PMID: 19897238
13. Pietilainen O, Laaksonen M, Rahkonen O, Lahelma E. Self-rated health as a predictor of disability retirement-the contribution of ill-health and working conditions. PLoS One. 2011; 6: e25004. doi: 10. 1371/journal.pone.0025004 PMID: 21949830
14. Wang M, Alexanderson K, Runeson B, Head J, Melchior M, Perski A, et al. Are all-cause and diagnosis-specific sickness absence, and sick-leave duration risk indicators for suicidal behaviour? A nationwide register-based cohort study of 4.9 million inhabitants of sweden. Occup Environ Med. 2014; 71: 12-20. doi: 10.1136/oemed-2013-101462 PMID: 24142975
15. WHO. International classification of diseases (ICD).; 2015.
16. WHO. Use of ATC/DDD. WHO;2015.
17. Lesen E, Sandstrom TZ, Carlsten A, Jonsson AK, Mardby AC, Sundell KA. A comparison of two methods for estimating refill adherence to statins in sweden: The RARE project. Pharmacoepidemiol Drug Saf. 2011; 20: 1073-1079. doi: 10.1002/pds.2204 PMID: 21853505
18. Kildemoes HW, Andersen M, Stovring H. The impact of ageing and changing utilization patterns on future cardiovascular drug expenditure: A pharmacoepidemiological projection approach. Pharmacoepidemiol Drug Saf. 2010; 19: 1276-1286. doi: 10.1002/pds.2039 PMID: 20954165
19. Lewey J, Shrank WH, Bowry AD, Kilabuk E, Brennan TA, Choudhry NK. Gender and racial disparities in adherence to statin therapy: A meta-analysis. Am Heart J. 2013; 165: 665-78, 678.e1. doi: 10.1016/j. ahj.2013.02.011 PMID: 23622903
20. Haukenes I, Riise T, Haug K, Farbu E, Maeland JG. Smokers' increased risk for disability pension: Social confounding or health-mediated effects? gender-specific analyses of the hordaland health study cohort. J Epidemiol Community Health. 2013; 67: 758-764. doi: 10.1136/jech-2012-202182 PMID: 23709663
21. Karlsson N, Borg K, Carstensen J, Hensing G, Alexanderson K. Risk of disability pension in relation to gender and age in a swedish county; a 12-year population based, prospective cohort study. Work. 2006; 27: 173-179. PMID: 16971764
22. von Bonsdorff ME, Huuhtanen P, Tuomi K, Seitsamo J. Predictors of employees' early retirement intentions: An 11-year longitudinal study. Occup Med (Lond). 2010; 60: 94-100. doi: 10.1093/occmed/kqp126 PMID: 19734239
23. Sjosten N, Nabi H, Westerlund H, Salo P, Oksanen T, Pentti J, et al. Effect of depression onset on adherence to medication among hypertensive patients: A longitudinal modelling study. J Hypertens. 2013; 31: 1477-84; discussion 1484. doi: 10.1097/HJH.0b013e32836098d1 PMID: 23666419
24. Lipsitz SR, Kim K, Zhao L. Analysis of repeated categorical data using generalized estimating equations. Stat Med. 1994; 13: 1149-1163. PMID: 8091041
25. Pettersson B, Hoffmann M, Wandell P, Levin LA. Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in sweden. Health Policy. 2012; 104: 84-91. doi: 10.1016/j.healthpol.2011.10.010 PMID: 22115548
26. Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, et al. Comparing policies to enhance prescribing efficiency in europe through increasing generic utilization: Changes seen and global implications. Expert Rev Pharmacoecon Outcomes Res. 2010; 10: 707-722. doi: 10.1586/erp.10.72 PMID: 21155704
27. Moran GM, Fletcher B, Feltham MG, Calvert M, Sackley C, Marshall T. Fatigue, psychological and cognitive impairment following transient ischaemic attack and minor stroke: A systematic review. European Journal of Neurology. 2014; 21: 1258-1267. doi: 10.1111/ene.12469 PMID: 24861479
28. Weber MT, Maki PM, McDermott MP. Cognition and mood in perimenopause: A systematic review and meta-analysis. J Steroid Biochem Mol Biol. 2014; 142: 90-98. doi: 10.1016/j.jsbmb.2013.06.001 PMID: 23770320
29. Vahtera J, Kivimaki M, Hublin C, Korkeila K, Suominen S, Paunio T, et al. Liability to anxiety and severe life events as predictors of new-onset sleep disturbances. Sleep. 2007; 30: 1537-1546. PMID: 18041486
30. Mann DM, Woodward M, Muntner P, Falzon L, Kronish I. Predictors of nonadherence to statins: A systematic review and meta-analysis. Ann Pharmacother. 2010; 44: 1410-1421. doi: 10.1345/aph.1P150 PMID: 20702755
31. Lemstra M, Blackburn D, Crawley A, Fung R. Proportion and risk indicators of nonadherence to statin therapy: A meta-analysis. Can J Cardiol. 2012; 28: 574-580. doi: 10.1016/j.cjca.2012.05.007 PMID: 22884278
32. Latry P, Molimard M, Begaud B, Martin-Latry K. How reimbursement databases can be used to support drug utilisation studies: Example using the main french national health insurance system database. Eur J Clin Pharmacol. 2010; 66: 743-748. doi: 10.1007/s00228-010-0819-0 PMID: 20429000
33. Grenard JL, Munjas BA, Adams JL, Suttorp M, Maglione M, McGlynn EA, et al. Depression and medication adherence in the treatment of chronic diseases in the united states: A meta-analysis. J Gen Intern Med. 2011; 26: 1175-1182. doi: 10.1007/s11606-011-1704-y PMID: 21533823
34. Oksanen T, Vahtera J, Westerlund H, Pentti J, Sjosten N, Virtanen M, et al. Is retirement beneficial for mental health?: Antidepressant use before and after retirement. Epidemiology. 2011; 22: 553-559. doi: 10.1097/EDE.0b013e31821c41bd PMID: 21502864
35. Westerlund H, Vahtera J, Ferrie JE, Singh-Manoux A, Pentti J, Melchior M, et al. Effect of retirement on major chronic conditions and fatigue: French GAZEL occupational cohort study. BMJ. 2010; 341: c6149. doi: 10.1136/bmj.c6149 PMID: 21098617
36. Murphy GK, McAlister FA, Eurich DT. Cardiovascular medication utilization and adherence among heart failure patients in rural and urban areas: A retrospective cohort study. Can J Cardiol. 2015; 31: 341-347. doi: 10.1016/j.cjca.2014.11.024 PMID: 25633910
37. Svensson E, Nielsen RB, Hasvold P, Aarskog P, Thomsen RW. Statin prescription patterns, adherence, and attainment of cholesterol treatment goals in routine clinical care: A danish population-based study. Clin Epidemiol. 2015; 7: 213-223. doi: 10.2147/CLEP.S78145 PMID: 25759601
38. Simeonova E. Marriage, bereavement and mortality: The role of health care utilization. J Health Econ. 2013; 32: 33-50. doi: 10.1016/j.jhealeco.2012.10.010 PMID: 23202255
39. Lemstra M, Blackburn D. Nonadherence to statin therapy: Discontinuation after a single fill. Can J Cardiol. 2012; 28: 567-573. doi: 10.1016/j.cjca.2012.03.018 PMID: 22658124
40. Helin-Salmivaara A, Lavikainen P, Korhonen MJ, Halava H, Junnila SYT, Kettunen R, et al. Long-term persistence with statin therapy: A nationwide register study in finland. Clin Ther. 2008; 30, Part 2: 2228-2240. doi: 10.1016/j.clinthera.2008.12.003 PMID: 19281917
41. Halava H, Korhonen MJ, Huupponen R, Setoguchi S, Pentti J, Kivimaki M, et al. Lifestyle factors as predictors of nonadherence to statin therapy among patients with and without cardiovascular comorbidities. CMAJ. 2014; 186: E449-56. doi: 10.1503/cmaj.131807 PMID: 24958839